TECH Bio-Techne · $72.12 Extended — don't chase; wait for a pullback过度拉升 — 勿追高;等待回撤 Terminal终端
Bio-Techne · Health Care

TECH

$72.12
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.Bio-Techne公司是一家美国生命科学公司,为研究、诊断和生物加工市场开发、制造并销售生命科学试剂、仪器和服务。
Broken growth成长受损 Large cap大盘 $11B
Engine stance引擎立场2026-07-20
Extended — don't chase; wait for a pullback过度拉升 — 勿追高;等待回撤
Stretched/late — protect gains and don't start new positions; let the next low set up first.已拉伸/晚期——保护利润,不要新开仓;先等下一个低点构筑成形。
Open in Terminal打开终端 All coverage所有股票 Data through数据截至 2026-07-20 · regenerated nightly每日更新

Key Statistics关键统计

Price价格
$72.12
0.0% below 52-week high0.0% below 52-week high
Market Cap市值
$11B
Normal volume正常成交量
P/E Ratio市盈率
153.2x
28.9x sector median
Beta贝塔
0.98
Moves about 1.0x the market波动幅度约为市场的 1.0 倍
RSI (14)RSI(14)
78
Overbought超买区域
Next Earnings下次财报
2026-08-05 (17d)
Volatility Rank波动率分位
86th pctile
hist. vol. percentile历史波动率分位数
Short Interest空头兴趣
10.2% of float

Performance价格表现

Period周期 TECH S&P 500vs Index对比指数
1 Week近1周 +1.2% -1.5% Beat the index by 2.7 points跑赢指数 2.7 个百分点
1 Month近1月 +31.1% +0.6% Beat the index by 30.5 points跑赢指数 30.5 个百分点
3 Months近3月 +22.0% +4.7% Beat the index by 17.3 points跑赢指数 17.3 个百分点
6 Months近6月 +5.4% +7.8% Lagged the index by 2.4 points落后指数 2.4 个百分点
Year to date年初至今 +21.3% +9.1% Beat the index by 12.2 points跑赢指数 12.2 个百分点
1 Year近1年 +36.2% +19.4% Beat the index by 16.8 points跑赢指数 16.8 个百分点

Technicals技术面

RSI (14)RSI(14) 78 Overbought超买区域
vs 50-day相对50日均线 +26.0% vs 50-day avg
vs 200-day相对200日均线 +22.4% vs 200-day avg
Volatility rank波动率分位 86th percentile 分位
Engine reference levels — not advice引擎参考水平 — 非投资建议
Buy zone买入区间
$69.81
Don't chase above不追高于
$72.12
Stop止损
$54.00
Extended — wait for a pullback过度拉伸 — 等待回撤

Earnings财务业绩

17
days until next report天后公布财报
2026-08-05

Estimates being cut预期下调

Earnings call transcripts — coming soon财报电话会议记录 — 即将上线

Valuation估值

Multiple指标 TECH Sector median行业中位 Cheaper than相对便宜
P/E (trailing)市盈率(历史) 153.16x 28.92
3%
P/B市净率 5.59x 3.52
27%
P/S市销率 9.22x 3.02
12%
Earnings yield盈利收益率 0.65% 2.72
28%
FCF yield自由现金流收益率 2.28% 3.94
26%
Shareholder yield股东收益率 2.90% 1.89
63%
EV/EBITDA企业价值/EBITDA 52.23x 18.21
13%
P/FCF市值/自由现金流 43.82x 22.42
15%
Analyst price targets — coming soon分析师目标价 — 即将上线

Financials财务数据

Revenue营业收入
$738.7M
2020
$931.0M
2021
$1.1B
2022
$1.1B
2023
$1.2B
2024
$1.2B
2025
5yr CAGR5年复合增速: 10.5%
Earnings Per Share每股收益
$5.82
2020
$3.47
2021
$6.63
2022
$1.76
2023
$1.05
2024
$0.46
2025
5yr CAGR5年复合增速: -39.8%
Free Cash Flow自由现金流
$153.5M
2020
$307.9M
2021
$280.4M
2022
$216.1M
2023
$236.1M
2024
$256.6M
2025
Margins利润率
Gross margin毛利率
64.8%
Operating margin营业利润率
8.4%
Net margin净利率
6.0%
FCF margin自由现金流利润率
23.6%
3.6%Return on Equity股本回报率
2.9%Return on Assets资产回报率
Leverage杠杆
Net debt / EBITDA净债务/EBITDA-0.76
Current ratio流动比率3.46
Capital Allocation资本配置
Buybacks (TTM)回购(TTM)$275.7M
Stock-based comp股权薪酬$40.8M
Share count change (1y)股数变化(1年)-1.3%
Piotroski皮奥特罗斯基 5/8 Altman Z阿尔特曼Z: safe (11.9) Clean稳健

Snapshot Gauges综合指标

Valuation vs Sector估值相对行业
Expensive vs sector相对行业偏贵
Cheaper than 16% of its sector on blended multiples综合估值倍数低于行业内 16% 的公司
Beta市场敏感度
0.98×
0.2
Moves about 1.0× the market波动幅度约为市场的 1.0 倍
Financial Health财务健康
5/8
Altman阿尔特曼: safe
Adequate financial health财务健康状况一般
Dividend分红
Does not pay a dividend不派发股息

Why Is It Moving为何波动

Sector / Theme行业/主题 Health Care (Equal-Weight) theme — #6 of 46 themes「医疗保健(等权)」主题 — 46 个主题中第 6 位
Macro宏观 Long-duration name into a restrictive, rising-real-rate regime → rate headwind.长久期标的进入偏紧、实际利率上行的环境→利率逆风。
Positioning持仓 Short interest changed -12.6%空头仓位变动 -12.6%
Technical技术面 TECH made a new 52-week highTECH 创52周新高

Ownership & Smart Money持仓与聪明钱

Insider activity内部人员活动: -$0.1M net (0 buyers, 1 sellers)-$0.1M 净值(0 买家,1 卖家)
Concentrated ownership集中持仓
Fund基金 Grade评级 Activity动作 % of portfolio组合占比 As of截至
Durable Capital Partners B Adding加仓 2.4% 2026-03-31

Signal History信号历史

UPTREND → NEARING A HIGH上涨趋势 → 接近高点
TAKE PROFITS. Late in the daily cycle (day 42 of ~23-44) — odds favor a dip into the next cycle low from here even with the trend intact止盈。处于日线周期晚期(约 23-44 天中的第 42 天)——即便趋势完好,从此处概率上仍倾向于回落至下一个周期低点
TOP WATCH NEARING A HIGH
Jul 15, 2026
TECH made a new 52-week highTECH 创52周新高
Price reached a fresh 52-week high — a momentum / trend extreme the whole market watches. $71.48.价格创出52周新高 — 全市场关注的动量/趋势极值。$71.48。
Jul 14, 2026
TECH daily MACD crossed downTECH 日线MACD下穿
The daily MACD histogram turned negative — fast and noisy, context rather than a standalone trigger. $71.23.日线MACD柱状图转负 — 快速且嘈杂,仅作背景。$71.23。
Jul 9, 2026
TECH made a new 52-week highTECH 创52周新高
Price reached a fresh 52-week high — a momentum / trend extreme the whole market watches. $71.15.价格创出52周新高 — 全市场关注的动量/趋势极值。$71.15。
Jul 1, 2026
NEARING A HIGH → UPTREND接近高点 → 上涨趋势
HOLD持有
Jun 30, 2026
UPTREND → NEARING A HIGH上涨趋势 → 接近高点
TAKE PROFITS止盈
Jun 25, 2026
UPTREND → NEARING A HIGH上涨趋势 → 接近高点
TAKE PROFITS止盈
Jun 25, 2026
TECH took relative-strength leadershipTECH 取得相对强弱领先
Relative strength vs SPY crossed above the 90th percentile of the last 90 days — leadership tends to persist. $70.70.相对标普500的强弱上穿近90日的第90百分位 — 领先往往延续。$70.70。
Jun 25, 2026
TECH RSI reached overboughtTECH RSI进入超买
RSI(14) crossed above 70 — stretched to the upside; context, not a timing trigger alone. $70.70.RSI(14)上穿70 — 上行过度;仅作背景,单独不构成择时。$70.70。
Jun 24, 2026
TECH reclaimed its 200-day averageTECH 收复200日均线
Price closed back above the 200-day moving average — the classic bull dividing line. $58.88.收盘重回200日均线 — 经典的多头分界线。$58.88。

Showing last 15 of显示最近15条,共 94 signals条信号

Factor Profile因子特征

Composite factor score综合因子得分: -0.11
Value价值
-0.9
Profitability盈利能力
-0.0
Quality质量
+0.4
Investment资本投入
+0.8
Shareholder payout股东回报
-0.3
Low volatility低波动
-0.7
Low market beta低市场敏感度
-0.2
Earnings quality盈利质量
+0.6
Short interest空头兴趣
+0.5

Company Profile公司档案

Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.Bio-Techne公司是一家美国生命科学公司,为研究、诊断和生物加工市场开发、制造并销售生命科学试剂、仪器和服务。
Watch items — what could change the thesis关注项 — 可能改变论点的因素
  • Margin compression despite revenue growth
Get the full picture获取完整视图
Nightly signals, options flow, and factor analysis across all S&P 500 names.每日更新的信号、期权资金流向和因子分析,覆盖所有标普500成分股。